Physician profile
Bryan T Holman
NPI 1225285083
$8,428.04
in general payments reported to CMS, 2019-2025
18 companies · $498 in 2025
The $498 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,331 · 2020: $1,865 · 2021: $628 · 2022: $408 · 2023: $974 · 2024: $725 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Entertainment: $767 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.94 |
| Entertainment | $767.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,996.12 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Optos, INC. | $1,545.89 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $656.89 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $609.74 | 2019-2021 | |
| Alcon Vision LLC | $434.76 | 2021-2025 | Total30, Tryptyr, Precision7 |
| Kala Pharmaceuticals, INC. | $349.42 | 2019-2021 | |
| Lkc Technologies, INC. | $147.30 | 2023-2025 | |
| Allergan, INC. | $136.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $126.29 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $99.40 | 2024-2025 | Xdemvy |
| Maculogix, INC. | $87.77 | 2019 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Topcon Healthcare, INC. | $47.36 | 2020 | |
| Sun Pharmaceutical Industries INC. | $34.45 | 2020 | |
| Oyster Point Pharma, INC. | $26.22 | 2023 | Tyrvaya |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $22.99 | 2024 | Vevye, Natacyn |
| Alcon Research LLC | $21.77 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Holman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.